(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 6.81% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.91%.
Radnet's revenue in 2025 is $1,907,872,000.On average, 10 Wall Street analysts forecast RDNT's revenue for 2025 to be $154,832,032,806, with the lowest RDNT revenue forecast at $146,832,762,358, and the highest RDNT revenue forecast at $160,677,653,518. On average, 9 Wall Street analysts forecast RDNT's revenue for 2026 to be $168,061,595,470, with the lowest RDNT revenue forecast at $157,293,346,790, and the highest RDNT revenue forecast at $176,368,530,166.
In 2027, RDNT is forecast to generate $179,214,424,460 in revenue, with the lowest revenue forecast at $165,215,701,176 and the highest revenue forecast at $190,982,581,946.